HomeOTLK • NASDAQ
add
Outlook Therapeutics Inc
Previous close
$2.41
Day range
$2.38 - $2.70
Year range
$0.87 - $8.32
Market cap
119.04M USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 1.51M | — |
Operating expense | 16.72M | -13.87% |
Net income | -20.15M | -145.38% |
Net profit margin | -1.34K | — |
Earnings per share | -0.44 | 46.70% |
EBITDA | -15.72M | 19.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.90M | -72.21% |
Total assets | 22.39M | -52.45% |
Total liabilities | 59.58M | -54.44% |
Total equity | -37.19M | — |
Shares outstanding | 44.42M | — |
Price to book | -2.80 | — |
Return on assets | -189.90% | — |
Return on capital | 4,812.47% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -20.15M | -145.38% |
Cash from operations | -11.90M | 39.01% |
Cash from investing | — | — |
Cash from financing | 13.25M | 207.49% |
Net change in cash | 1.34M | 108.84% |
Free cash flow | -5.45M | 58.32% |
About
Founded
2010
Website
Employees
23